Christine Probst
Christine Probst publishes mostly in Molecular Biology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, on topics such as Protein purification and stability, Microfluidic and Bio-sensing Technologies and Viral Infectious Diseases and Gene Expression in Insects.
- World rank
- #3,927,948 of 7,710,434 ranked researchers
- Rank in United States
- #1,075,449 of 1,627,098
- Works
- 19
- Citations
- 1.2k
- Citations per work
- 61.8
What does Christine Probst research?
Christine Probst's work is mostly in Biochemistry, Genetics and Molecular Biology (46%), Medicine (20%), Engineering (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences946.3%
- Health Sciences420.4%
- Medicine420.4%
- Physical Sciences316.7%
- Engineering213.0%
- Materials Science13.7%
- Everything else316.6%
- 1Molecular Biology37% of their works
- 2Biomedical Engineering13% of their works
- 3Radiology, Nuclear Medicine and Imaging13% of their works
- 4Cancer Research9% of their works
- 5Ophthalmology7% of their works
- 6Materials Chemistry4% of their works
Research topics
- Protein purification and stability
- Microfluidic and Bio-sensing Technologies
- Viral Infectious Diseases and Gene Expression in Insects
- Monoclonal and Polyclonal Antibodies Research
- MicroRNA in disease regulation
- Carcinogens and Genotoxicity Assessment
- Single-cell and spatial transcriptomics
- Advanced biosensing and bioanalysis techniques
Which keywords describe Christine Probst's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Biopharmaceuticals, Glycosylation, Protein Aggregation, Gene Expression, Microfluidics and Particle Separation.
- Transcriptomics
- Self-Assembly
- Genotoxicity Testing
- Comet Assay
- Recombinant Protein
- Fc Receptors
- Particle Separation
- Gene Expression
- Glycosylation
- Therapeutic Antibodies
- Monoclonal Antibodies
- Biopharmaceuticals
- Protein Aggregation
- Microfluidics
- Antibody Engineering
- Mammalian Cells
- Cancer
- DNA nanotechnology
- MicroRNA
- Single-Cell
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Monoclonal Antibodies92 topics
- Therapeutic Antibodies92 topics
- Biopharmaceuticals61 topic
- Glycosylation62 topics
- Protein Aggregation61 topic
- Gene Expression42 topics
- Microfluidics41 topic
- Particle Separation41 topic
- Antibody Engineering31 topic
- Fc Receptors31 topic
- Mammalian Cells31 topic
- Recombinant Protein31 topic
- Cancer21 topic
- Comet Assay21 topic
- DNA nanotechnology21 topic
- Genotoxicity Testing21 topic
- MicroRNA21 topic
- Self-Assembly21 topic
- Single-Cell21 topic
- Transcriptomics21 topic
Where does Christine Probst work?
Christine Probst's main affiliation in the publication record is Luminex (United States), United States.
How many publications and citations does Christine Probst have?
OpenAlex counts 19 works and 1,174 citations for Christine Probst, an h-index of 13, ranking #3,927,948 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christine Probst. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.